-
Interview with the CEO: Merge Healthcare Incorporated (MRGE)
Jeff Surges
-
Investing in Health, Cloud Computing and Mobile
George B. Bolton
-
Interview with the Senior Vice President and CFO: athenahealth, Inc. (ATHN)
Timothy Adams
-
Interview with the Senior Vice President and Chief Service & Information Officer: Humana Inc. (HUM)
Brian LeClaire
-
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro
-
Interview with the Founder, Chairman and CEO: NovaBay Pharmaceuticals, Inc. (NBY)
Ramin Najafi
-
FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
Brian Skorney
-
Identifying Hidden Value and Market Opportunities in Biotech Companies
Ian Somaiya
-
Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugs
Boris Peaker
-
Interview with the Founder, Chairman, President and CEO: Dyadic International (DYAI)
Mark A. Emalfarb
-
Alternative Dosage Forms Create Barriers Against Competition in Generics
David Amsellem
-
High Success Rates and Significant M&A in the Antibody Space
Dr. Jason Kantor
-
Interview with the President and CEO: Innovus Pharmaceuticals, Inc. (INNV)
Bassam Damaj
-
Medical Device Companies Outperform Benchmarks Despite European Concerns
Joanne K. Wuensch
-
Small and Midcap Medical Device Companies Benefit from Less Exposure to Europe
Steven M. Lichtman
-
Interview with the CEO and President: Vasomedical, Inc. (VASO)
Jun Ma, Ph.D.
-
Interview with the CEO: Atossa Genetics, Inc. (ATOS)
Steven Quay
-
Opportunities in Advanced Surgical Technology for Medical Device Companies
Matt Miksic
-
Interview with the President, CEO and Director: NeuroMetrix, Inc. (NURO)
Shai N. Gozani
-
Interview with the Executive Vice President and CFO: Catamaran Corporation (CTRX)
Jeff Park
-
Interview with the Managing Director and Health Industry Lead for North America: Accenture plc (ACN)
Kaveh Safavi, M.D.
-
EHR Expansion Continues to Drive Growth in Health IT Space
Michael Cherny
-
Constructive Outlook on Health Care IT Tied to Drug Development and Fraud Prevention
David H. Windley
-
Interview with the President and CEO: Streamline Health, Inc. (STRM)
Robert E. Watson
-
Demographics Favor More and Quicker Adoption of Private-Sector Solutions
Thomas Carroll
-
Interview with the CEO of Emerging Businesses: Aetna Inc. (AET)
Charles E. Saunders, M.D.
-
Interview with the Executive Vice President and Global Chief Information Officer: Cigna Corp. (CI)
Mark Boxer
-
Emerging-Growth Opportunities in Oncology Biotech
Boris Peaker
-
Hepatitis C Therapies Propel Growth in Biotech
Matthew Roden
-
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
Jim Birchenough
-
PDL BioPharma, Inc. (PDLI)
John P. McLaughlin
-
Cyclacel Pharmaceuticals, Inc. (CYCC)
Spiro Rombotis
-
Rigel Pharmaceuticals, Inc. (RIGL)
Raul R. Rodriguez
-
Hadasit Bio-Holdings Ltd. (HADSY)
Ophir Shahaf
Medical Research, Diagnostic Substances and Life Science Tools
August 20, 2012
» See all the topics and companies covered
-
Chinese Medical Research and Biotech Companies Set to Outpace Western Peers
Ingrid Yin
-
Higher-Efficiency Plays in Research and Diagnostics Despite Bearish Sentiments
Amit Bhalla
-
Aethlon Medical, Inc. (AEMD)
James A. Joyce
-
Cleveland BioLabs, Inc. (CBLI)
Yakov Kogan
-
Corgenix Medical Corp. (CONX)
Douglass T. Simpson
-
Enzo Biochem, Inc. (ENZ)
Barry W. Weiner, David C. Goldberg
-
Albany Molecular Research, Inc. (AMRI)
Mark T. Frost
-
Diagnostics Display Pricing Power Despite Macro and Regulatory Uncertainty
Vamil Divan, M.D.
-
NanoViricides, Inc. (NNVC)
Eugene Seymour, M.D.
-
NeoStem, Inc. (NBS)
Robin L. Smith, M.D.
-
Increasing Outsourcing of R&D to Benefit Chinese Medical Research Firms
Jason Mann, M.D.
More Reports










